GSK3-inhibition improves maximal SERCA activity in a murine model of Arrhythmogenic cardiomyopathy is a research paper published in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Heart Association
Grant: 19CDA34760185
National Institutes of Health
Grant: R01HL148348
National Institutes of Health
Grant: RO1
Canadian Institutes of Health Research
Grant: unidentified
unidentified
Canadian Institutes of Health Research
Canada Research Chairs
CIHR
FWCI
0.77
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals